The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The persistence of PFAS in the environment and potential health risks have led to regulatory actions affecting the medical device industry. In this blog, learn key PFAS details and how to address PFAS challenges for medical device companies.
Generic drugs play an important role in healthcare, but bringing them to market can be complex, cost-prohibitive, and time-consuming. This six-phase approach to creating generic drug-device combination products (g-DDCPs) aims to simplify the process.
Learn how AI technologies evolved throughout the years, how Battelle used (and is using) AI to develop life-changing medical devices, and how to responsibly advance medical device innovation in the "AI Age".
During the water treatment process, contaminants such as transformation products (TPs) can emerge. Learn more about transformation products, why they matter and what Battelle can do to help.
Discover the effect of PFAS regulations on the medical device industry, and explore our experts' 5 strategies to help medical device companies adapt to this evolving landscape.
Follow along with the latest news, announcement and updates from our Battelle community of solvers.
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. By continuing to browse our
site without changing your settings, you are agreeing to accept all cookies on the site.
